Home › NCT07534462

Echocardiographic Assessment of the Effect of Impella on Biventricular Function

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Adult patients over 18 years old
2. Require Impella 5.5 implantation

Exclusion Criteria:

1. Patients' inability to provide consent for themselves (including that patients' lack of understanding the research)
2. Any patients who are deemed at higher-than-normal risk for complications secondary to echocardiography, such as dysphagia or esophageal pathology

About the study

The objective of this prospective observational study is to evaluate the effects of Impella 5.5 on biventricular function in adult patients with end-stage heart failure requiring temporary mechanical circulatory support. The study will assess changes in left and right ventricular global longitudinal strain and myocardial work, as well as additional echocardiographic and hemodynamic parameters. Measurements will be obtained at baseline prior to Impella implantation, immediately after device initiation, and during postoperative follow-up up to Day 14. This study involves collection of echocardiographic imaging and clinical data, including additional imaging performed for research purposes.

What is being tested

• Echocardiographic Assessment (diagnostic test)

Sponsor: University of Rochester · Participants: 24 · Started: Jul 11, 2026

Contact the study team

• YOSHIHISA MORITA · Phone: 585-275-2141
• Tammy Ortiz · Phone: 585-276-0005

Official record on ClinicalTrials.gov — NCT07534462

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.